IL6 and COVID-19: This control cohort would have consisted of patients receiving the standard of care (SoC) treatment without LDRT, enabling a comparative analysis of plasma COVID-19 viral load evolution, mortality ratio, length of hospitalization, viral RNA, and IL-6 concentration with the experimental cohort treated with SoC plus LDRT.